Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel tachykinin NK1 receptor antagonists disclosed by Roche

Jan. 22, 2001

Biogen's Avonex meets primary endpoint in study of secondary progressive MS

Jan. 22, 2001

January launch for MyoBloc injectable solution for cervical dystonia

Jan. 22, 2001

Inhibitors of NOS and their therapeutic use claimed in recent patents by AstraZeneca

Jan. 19, 2001

New series of 5-HT7 antagonists designed by the former SB

Jan. 19, 2001

Novel combination therapies useful for weight gain associated with antipsychotic drugs

Jan. 19, 2001

Novel agents for epilepsy and other CNS disorders a focus of investigation at Pfizer

Jan. 18, 2001

Structurally novel series of 5-ht6 receptor antagonists evaluated for SAR

Jan. 18, 2001

In vivo evidence supporting bone marrow as a source of neural cells

Jan. 18, 2001

Adenosine uptake inhibitors useful for cerebral ischemia patented by Bayer

Jan. 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...